The study’s technical approach is what sets it apart from the questionnaire-based surveys that have dominated Indonesian national health surveillance. Rather than relying primarily on interviews, the researchers put every willing participant through a battery of objective measurements. Anthropometric assessments captured body mass index and waist circumference, blood pressure was measured with calibrated devices, and each subject received a single-lead electrocardiogram to probe for silent rhythm abnormalities. Crucially, blood was drawn for biochemical analysis, including glycated hemoglobin, or HbA1c, which reflects average blood glucose over roughly three months, and a full lipid panel measuring cholesterol fractions including low-density lipoprotein. This laboratory anchoring matters because prior nationwide efforts, such as the Indonesian Health Survey of 2023, largely depended on self-reported history and tested only a limited subset of respondents with oral glucose tolerance tests and biochemical lipid profiling, leaving substantial blind spots in prevalence estimates.

The metabolic findings were perhaps the most dramatic. Sixty-nine percent of participants met criteria for obesity, a further 15 percent were overweight, and 83 percent had elevated waist circumference, a marker of central adiposity that is increasingly recognized as an independent predictor of cardiometabolic risk. Central obesity, in which fat accumulates around the abdominal organs, is metabolically active tissue that promotes insulin resistance, raises blood pressure and dysregulates lipid metabolism. That more than eight in ten screened adults carried excess abdominal fat, in a population where 80 percent of participants were women, points to a profound nutritional and lifestyle transition in this semi-urban setting. Indonesia, like much of Southeast Asia, has seen rapid shifts in diet and physical activity patterns over recent decades, and these data offer one of the clearest snapshots yet of what that transition means for the cardiovascular health of a working-age and older population outside the major megacities.

The screening also caught a quieter danger. Using the single-lead electrocardiogram, the team identified atrial fibrillation in 1.3 percent of subjects. Atrial fibrillation is an irregular heart rhythm that dramatically increases the risk of ischemic stroke, often presenting with no symptoms at all until a clot-related catastrophe occurs. Detecting it in a community cohort of adults without known cardiovascular disease underscores the value of including simple, inexpensive rhythm screening in population health programs. A single-lead ECG takes minutes and requires modest equipment, yet it can flag individuals who would benefit from anticoagulation therapy and closer follow-up, potentially preventing disabling strokes before they happen.

To understand who was most at risk, the researchers turned to multivariable logistic regression, a statistical technique that estimates the independent association between each candidate factor and an outcome while holding the others constant. The analysis showed that the presence of cardiovascular risk factors was significantly associated with older age, obesity and elevated waist circumference. These associations align with the established pathophysiology of atherosclerosis and metabolic disease, in which adiposity drives hypertension, insulin resistance and dyslipidemia over decades of exposure. But the regression results also carry a public health message: the risk factor burden in this population concentrates in identifiable, measurable subgroups, meaning targeted screening and intervention programs could plausibly reach the people who need them most without screening everyone identically.

Beyond physiology, the study probed the psychology of prevention. A subset of participants completed a 14-point questionnaire assessing knowledge, attitudes and practices, commonly abbreviated KAP in global health research. The median knowledge score was just 5 out of 10, and the median combined KAP score was 9 out of 14, revealing substantial gaps in what these adults understood about cardiovascular risk factors and how to control them. Further regression analysis suggested that KAP scores rose with education level but were unrelated to occupation, hinting that formal schooling, rather than workplace environment, shapes cardiovascular health literacy in this setting. Strikingly, the researchers found no significant relationship between KAP scores and the actual presence of cardiovascular risk factors. Knowing what is unhealthy, in other words, did not translate into measurably healthier risk profiles among those screened.

That disconnect between knowledge and behavior is a familiar puzzle in chronic disease prevention, but its scale here is notable. Health communication campaigns that simply inform people about the dangers of salt, sugar, tobacco and inactivity may be necessary but insufficient when the environments in which people eat, work and age make healthy choices difficult. In semi-urban North Sumatera, where community health infrastructure includes PUSKESMAS, the government community health centers, and POSBINDU, the integrated development posts designed for noncommunicable disease monitoring, the study’s findings suggest these channels exist but are not yet detecting or managing risk at the scale required. With more than half of screened adults hypertensive and most of those cases newly identified, the gap between the population’s need and the system’s reach is wide.

The study’s design deserves scrutiny as well as praise. Recruitment was opportunistic rather than a random population sample, meaning participants were people who came forward at screening sites, and four-fifths of them were women. Prevalence estimates drawn from such a cohort may not perfectly mirror the general adult population of North Sumatera, and the researchers are careful to frame the work as community-based screening rather than definitive epidemiology. Even so, the objective biochemical and instrumental measurements give the numbers a solidity that interview-based surveys cannot match, and the sheer proportion of newly diagnosed hypertension, diabetes and dyslipidemia among ostensibly healthy adults is unlikely to be an artifact. If anything, self-selection into a screening program would be expected to attract more health-conscious individuals, suggesting the true population burden could be still higher.

The ECARDIA-NS partnership between Universitas Sumatera Utara and the SingHealth Duke-National University of Singapore Global Health Institute, funded through pilot grants from both institutions, offers a model for how regional collaboration can generate locally actionable data. The authors conclude that the high burden of cardiometabolic disease, combined with the knowledge gaps the KAP survey exposed, indicates that considerably more work remains to be done in the region to address cardiovascular risk. Their findings arrive at a moment when low- and middle-income countries across Asia are confronting the collision of aging populations with rising obesity and diabetes, and when global health agencies are pressing for primary prevention strategies that identify risk before the first heart attack or stroke. In Medan and its surrounding districts, the message from this study is unambiguous: the risk factors are there, they are common, they are largely silent, and they are waiting to be found by anyone willing to measure a blood pressure, draw a blood sample and look.

Subject of Research: Prevalence and detection of cardiovascular risk factors among semi-urban adults in North Sumatera, Indonesia

Article Title: Prevalence of cardiovascular risk factors in a semi-urban population in Indonesia [Early detection of cardiovascular risk factors as primary prevention amongst North Sumatera adults (ECARDIA-NS) study]

Article References: Siregar, Y. F., Tern, P. J. W., Lei, J., Ilyas, K. K., Raynaldo, A. H., Sarastri, Y., Haykal, T. B., Andra, C. A., Habib, F., Hasan, R., Siregar, D. I. S., Koh, S. J. Q., Koh, A. S.-M., Tan, J. W. C., & Lubis, A. C. (2026). Prevalence of cardiovascular risk factors in a semi-urban population in Indonesia [Early detection of cardiovascular risk factors as primary prevention amongst North Sumatera adults (ECARDIA-NS) study]. BMC Public Health. https://doi.org/10.1186/s12889-026-29179-y

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29179-y

Keywords: cardiovascular risk factors, hypertension, diabetes, dyslipidemia, obesity, Indonesia, North Sumatera, population screening, primary prevention, atrial fibrillation, public health, Prevalence

The core of this research centers on metabolomics — the comprehensive study of metabolites, which are the small molecules involved in metabolism within cells, tissues, or organisms. Traditionally, metabolomic profiling requires invasive procedures and significant processing time, limiting its applicability in regular health assessments. However, the utilization of retinal tissue from the RNFL presents a non-invasive, accessible, and highly informative biomarker source. The retinal nerve fibre layer, composed of unmyelinated axons of retinal ganglion cells, reflects systemic physiological states in a unique way, encompassing both neurological and vascular components critical to understanding overall health and disease progression.

Artificial intelligence becomes indispensable in this context due to the intricate and vast data generated by metabolomic analysis. High-throughput mass spectrometry and other advanced biochemical profiling instruments produce rich datasets with thousands of measured metabolites. Extracting meaningful patterns that correlate with disease risk and mortality from this data demands robust computational methods. AI algorithms, particularly deep learning architectures, excel at detecting subtle, multidimensional relationships within the dataset that human analysts might overlook. The research team deployed these AI models to integrate metabolomic signals from the RNFL and correlate them with longitudinal health outcomes, including incidences of cardiometabolic conditions and mortality statistics.

One particularly compelling aspect of the study is the establishment of a predictive metabolomic signature from retinal tissue, which showed remarkable accuracy in stratifying individuals by their risk of fatal and non-fatal cardiometabolic events. Cardiometabolic diseases — encompassing conditions such as coronary artery disease, stroke, diabetes, and related metabolic disorders — remain leading causes of morbidity and mortality worldwide. Current risk assessments rely heavily on clinical metrics and blood markers, which, while informative, might miss subtle signals discernible deep within tissue-specific metabolomic landscapes. The RNFL’s metabolic profile offers an unprecedented window into systemic disease dynamics at an early, potentially reversible stage.

Moreover, the AI-driven approach circumvents several challenges traditionally associated with biomarker discovery. By automating feature extraction and selection processes, the system reduces biases inherent in manual analysis and enhances reproducibility across different populations and scanning platforms. The model’s adaptability means it can continuously improve with added data, reflecting new patient cohorts or emerging health trends. This dynamic learning capability is crucial for tailoring personalized health strategies and could revolutionize how clinicians approach preventive care for high-risk individuals.

The implications of this research extend beyond mortality prediction. Given the retina’s embryological origin as an extension of the central nervous system, metabolomic analysis of the RNFL could potentially illuminate mechanisms underlying neurodegenerative diseases and other systemic disorders with metabolic underpinnings. Early detection and intervention in these conditions depend on sensitive biomarkers capable of tracking disease evolution at a granular molecular level, a role this retinal metabolomics-AI fusion is uniquely positioned to fulfill.

This paradigm shift also underscores the emerging importance of integrating cross-disciplinary expertise — combining ophthalmology, biochemistry, computational science, and clinical epidemiology — to harness AI’s full potential in medicine. The study’s success is a testament to how advanced imaging and metabolomic profiling platforms, coupled with cutting-edge computational algorithms, can unveil biological insights that were previously unattainable. It charts a roadmap for future investigations aiming to expand AI-driven metabolomics to other accessible tissues or biofluids.

Beyond the science, the prospect of a rapid, non-invasive, and highly accurate diagnostic tool has profound public health implications. Cardiometabolic diseases place an enormous burden on healthcare systems through chronic morbidity and acute life-threatening events. Early identification of at-risk individuals, enabled by this retinal metabolomics analytics, could facilitate timely lifestyle or pharmacological interventions to mitigate disease progression, ultimately lowering population-level mortality rates.

While the study demonstrates tremendous promise, implementation in clinical practice will require further validation through large-scale, multicenter trials and longitudinal studies. Ensuring consistency across diverse demographic groups and linking retinal metabolomic profiles with genetic, environmental, and lifestyle factors remains an essential next step. Additionally, ethical considerations concerning data privacy, AI transparency, and accessibility must be addressed to realize equitable deployment of these advanced diagnostic tools.

Future research directions hinted by these findings include expanding the metabolite database specific to retinal tissues and enhancing AI models to dissect complex interactions between metabolic pathways. Researchers anticipate that refinement in AI explainability methods will also play a critical role in gaining clinicians’ trust and facilitating regulatory approval processes. Ultimately, this confluence of AI and retinal metabolomics represents a paradigm shift towards personalized, predictive, and preventive healthcare.

This study exemplifies how leveraging the synergy between artificial intelligence and metabolomic profiling can unravel subtle biological signatures crucial for disease prediction. The retinal nerve fibre layer emerges as a valuable bio-indicator, capable of reflecting systemic health statuses through molecular fingerprints decipherable by AI. As researchers continue to integrate diverse data layers, from genomics to imaging, the future of precision medicine appears increasingly intertwined with such interdisciplinary innovations.

It is anticipated that the adoption of AI-driven metabolomic approaches alongside traditional clinical assessments will soon become standard practice for evaluating cardiometabolic health. Such a future promises not just improved patient outcomes but also a profound transformation in our understanding of disease biology at the molecular level. This new capability may usher in an era where a simple retinal scan can provide comprehensive insights into an individual’s mortality risk and guide targeted interventions well before clinical symptoms manifest.

By harnessing the retina’s unique accessibility combined with cutting-edge AI analytics, the research team has positioned retinal metabolomics at the frontier of clinical diagnostics. This pioneering work not only informs strategies to combat cardiometabolic disease but also establishes a methodological blueprint for leveraging metabolomic signatures from other tissues to tackle a broad spectrum of diseases.

In conclusion, the marriage of artificial intelligence with metabolomics of the retinal nerve fibre layer heralds a new age in biomedicine, where non-invasive molecular diagnostics can robustly inform health risk profiling. With continued innovation and validation, this technology holds the potential to significantly reduce global mortality burdens by enabling earlier, more precise interventions against cardiometabolic and potentially other systemic diseases.

Subject of Research: Artificial intelligence-driven metabolomics analysis of the retinal nerve fibre layer to predict mortality and cardiometabolic disease risks.

Article Title: Artificial intelligence-driven metabolomics of retinal nerve fibre layer to profile risks of mortality and cardiometabolic diseases.

Article References: Yang, S., Xin, Z., Li, H. et al. Artificial intelligence-driven metabolomics of retinal nerve fibre layer to profile risks of mortality and cardiometabolic diseases. Nat Commun 16, 11039 (2025). https://doi.org/10.1038/s41467-025-66979-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-025-66979-z

Sarcopenic obesity, characterized by an excess of fat mass coupled with a reduction in muscle mass, poses significant health hazards, particularly for older adults. This condition can exacerbate the risks of disability, metabolic disorders, and overall mortality. Traditional measures for assessing obesity, such as Body Mass Index (BMI), often obscure the underlying muscle composition. This disconnect highlights the need for alternative screening methods that can effectively identify individuals at risk of adverse health outcomes due to muscular decline and excessive fat accumulation.

Cheng and colleagues have investigated the efficacy of the WAR as a practical substitute for more complex and sometimes invasive assessments. By examining the relationship between waist circumference, arm circumference, and health markers, the researchers have established WAR as an intuitive indicator that is easy to calculate and interpret. This methodology aligns with the growing demand for straightforward, accessible health assessments that can be employed outside clinical environments, particularly in community settings where professional resources may be limited.

The study involved a meticulous analysis of older adults, carefully considering various parameters such as age, gender, and physical activity levels. Participants were required to undergo comprehensive evaluations that assessed body composition alongside relevant metabolic indicators. This rigorous approach ensures that the findings are grounded in robust empirical data, reinforcing the reliability of the WAR as a screening tool.

In their results, Cheng et al. demonstrated that a higher WAR was significantly associated with unfavorable metabolic profiles, including insulin resistance and increased levels of inflammation. These findings suggest that individuals with elevated WAR not only face increased obesity risks but also may be situated on a trajectory toward various chronic diseases. The implications of these results extend beyond immediate health concerns, potentially informing broader public health strategies aimed at mitigating the burden of sarcopenic obesity in aging populations.

The ease of calculating the WAR offers significant benefits for health practitioners and researchers alike. Unlike other metrics that require specialized equipment or trained personnel, WAR necessitates only basic measurement tools such as a tape measure. This practicality encourages its adoption in various settings, including outpatient clinics, community health initiatives, and large-scale epidemiological studies. The accessibility of such a tool empowers community health workers to identify at-risk individuals more readily and promote timely interventions.

An additional advantage of using the WAR lies in its potential to foster awareness about body composition among older adults. By integrating this metric into regular health check-ups, individuals may become more cognizant of their body composition and its implications for their overall health. Educating older adults about the risks associated with sarcopenic obesity and emphasizing the importance of maintaining muscle mass could instigate behavioral changes conducive to healthier lifestyles.

The ramifications of the study extend beyond individual health. If more healthcare providers embrace the WAR as a primary screening tool, we could see a paradigm shift in how sarcopenic obesity is understood and managed. The integration of WAR into routine health assessments could lead to preventive strategies that prioritize muscle maintenance and fat management, thereby safeguarding the wellbeing of older individuals.

As the population ages, addressing the complexities surrounding sarcopenic obesity will be paramount in fostering healthy aging. Cheng and colleagues’ work highlights the importance of adaptability in health screenings, encouraging a move away from one-size-fits-all metrics toward more nuanced approaches that consider diverse demographic factors. Such flexibility will be crucial in effectively identifying at-risk individuals and developing tailored interventions designed to optimize health outcomes.

In conclusion, Cheng et al.’s research presents compelling evidence for the Waist-to-Arm Ratio as a simple yet effective tool for screening sarcopenic obesity in older adults. Their findings advocate for a broader adoption of this metric in both clinical and community settings, potentially enhancing early detection and intervention efforts. As the healthcare landscape continues to evolve in response to an aging population, adopting innovative, user-friendly tools like the WAR will be essential to improving geriatric health outcomes and promoting sustainable longevity.

Moreover, the potential expansion of the use of WAR beyond the confines of the research highlights the prospects of a more proactive approach to geriatric health management. By fostering an environment of awareness around body composition, healthcare systems can cultivate a culture that prioritizes muscle health and metabolic well-being among older adults.

Health professionals, caregivers, and older individuals stand to benefit immensely from integrating the Waist-to-Arm Ratio into their health routines. This simple index could be the key to unlocking healthier aging, ensuring that older adults not only survive but thrive in their golden years. Future studies could explore the applicability of WAR across different populations, assessing its versatility and efficacy among varied ethnicities and lifestyles.

Subject of Research: Sarcopenic obesity screening in older adults.
Article Title: Waist-to-arm ratio is a simple and effective index for screening the sarcopenic obesity in older adults.
Article References: Cheng, G., Zhou, Y., Wang, Y. et al. Waist-to-arm ratio is a simple and effective index for screening the sarcopenic obesity in older adults. BMC Geriatr 25, 981 (2025). https://doi.org/10.1186/s12877-025-06618-w
Image Credits: AI Generated
DOI: https://doi.org/10.1186/s12877-025-06618-w
Keywords: Sarcopenic obesity, Waist-to-arm ratio, Older adults, Health screening, Body composition.